MedPath

pyridostigmine bromide

Pyridostigmine Bromide Tablets, USP Rx only

Approved
Approval ID

36284496-e56e-466c-9b56-6007bb5bb699

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 14, 2021

Manufacturers
FDA

Major Pharmaceuticals

DUNS: 191427277

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pyridostigmine bromide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0904-6622
Application NumberANDA205650
Product Classification
M
Marketing Category
C73584
G
Generic Name
pyridostigmine bromide
Product Specifications
Route of AdministrationORAL
Effective DateMay 4, 2017
FDA Product Classification

INGREDIENTS (5)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
PYRIDOSTIGMINE BROMIDEActive
Quantity: 60 mg in 1 1
Code: KVI301NA53
Classification: ACTIB
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

pyridostigmine bromide - FDA Drug Approval Details